Vaccine Therapy and Autologous Lymphocyte Infusion With or Without Fludarabine in Treating Patients With Metastatic Melanoma - Related Studies

Vaccine Therapy and Autologous Lymphocyte Infusion With or Without Fludarabine in Treating Patients With Metastatic Melanoma

This study is currently recruiting participants.

Study NCT00313508. Last updated on November 18, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Intraocular Melanoma
		Melanoma (Skin)

2	Additional conditions recognized in this trial
		Eye Neoplasms
		Melanoma

3	More general conditions related to this trial
		Eye Diseases
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Nerve Tissue
		Neuroectodermal Tumors
		Neuroendocrine Tumors
		Nevi and Melanomas

4	Interventions listed in this trial
		fludarabine phosphate
		therapeutic autologous lymphocytes
		dendritic cell vaccine therapy

5	Additional drug interventions recognized in this trial
		Fludarabine
		Fludarabine monophosphate

6	More general drug interventions related to this trial
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

7	Sponsors listed in this trial
		H. Lee Moffitt Cancer Center and Research Institute
		National Cancer Institute (NCI)